These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30928247)

  • 1. Effects of dietary-fiber levels on RANK/RANKL/OPG expression in the appendix of weanling rabbits.
    Zhu Y; Sun Y; Zhang N; Li F; Zhou H
    J Microbiol Immunol Infect; 2020 Oct; 53(5):696-704. PubMed ID: 30928247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis.
    Song HM; Wei YC; Li N; Wu B; Xie N; Zhang KM; Wang SZ; Wang HM
    Mol Med Rep; 2015 Dec; 12(6):8155-61. PubMed ID: 26496816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of technetium-99 conjugated with methylene diphosphonate (
    Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
    J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway.
    Zhao JJ; Wu ZF; Wang L; Feng DH; Cheng L
    PLoS One; 2016; 11(7):e0159805. PubMed ID: 27459539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis.
    Stuss M; Rieske P; Cegłowska A; Stêpień-Kłos W; Liberski PP; Brzeziańska E; Sewerynek E
    J Clin Endocrinol Metab; 2013 May; 98(5):E1007-11. PubMed ID: 23543663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L; Marotta Pdos S; Pires FR; Siqueira JF
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
    Wang Z; Ding L; Zhang S; Jiang T; Yang Y; Li R
    Int J Mol Med; 2014 Dec; 34(6):1720-6. PubMed ID: 25270538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
    Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
    BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
    Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
    Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
    Wang J; Wang K; Shi Z; Zhang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats.
    de Amorim FP; Ornelas SS; Diniz SF; Batista AC; da Silva TA
    J Mol Histol; 2008 Aug; 39(4):401-8. PubMed ID: 18592139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANK/RANKL/OPG system in the intervertebral disc.
    Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
    Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints.
    Spahni AI; Schawalder P; Rothen B; Bosshardt DD; Lang N; Stoffel MH
    Vet Surg; 2009 Aug; 38(6):780-6. PubMed ID: 19674422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.
    Vitovski S; Phillips JS; Sayers J; Croucher PI
    J Biol Chem; 2007 Oct; 282(43):31601-9. PubMed ID: 17702740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity.
    Kimura S; Nakamura Y; Kobayashi N; Shiroguchi K; Kawakami E; Mutoh M; Takahashi-Iwanaga H; Yamada T; Hisamoto M; Nakamura M; Udagawa N; Sato S; Kaisho T; Iwanaga T; Hase K
    Nat Commun; 2020 Jan; 11(1):234. PubMed ID: 31932605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Oike N; Sasaki T; Hatano H; Ohashi R; Umezu H; Ajioka Y; Endo N
    Tohoku J Exp Med; 2019 Jun; 248(2):87-97. PubMed ID: 31189751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.